Denali Therapeutics Inc. logo DNLI - Denali Therapeutics Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 18
HOLD 0
SELL 0
STRONG
SELL 0
| PRICE TARGET: $30.80 DETAILS
HIGH: $40.00
LOW: $23.00
MEDIAN: $31.00
CONSENSUS: $30.80
UPSIDE: 65.24%

Profitability Ratios

Ratio Value
GP Margin 0.0%
EBIT Margin 0.0%
EBITDA Margin 0.0%
Operating Margin 0.0%
Pretax Margin 0.0%
Cont. Ops Margin 0.0%
Net Margin 0.0%
Bottom Line Margin 0.0%

Liquidity Ratios

Ratio Value
Current Ratio 9.16
Quick Ratio 9.16
Solvency Ratio -3.797
Cash Ratio 2.09

Valuation Ratios

Ratio Value
Price/Earnings
-5.65
Hist. avg: 128.3
Peers avg: 23.2
PEG Ratio -0.36
Forward PEG -0.36
Price/Book 2.86
Price/Sales 0.00
Price/FCF -6.86
Price/Op Cash Flow -7.02

Debt Ratios

Ratio Value
Debt/Assets 0.0369
Debt/Equity 0.0417
Debt/Capital 0.0400
Long-Term Debt/Capital 0.0000
Financial Leverage 1.13

Cash Flow Ratios

Ratio Value
Working Capital Turnover 0.00
Operating Cash Flow Ratio -4.195
Operating Cash Flow/Sales 0.0%
Free Cash Flow/Operating Cash Flow 102.3%

Coverage Ratios

Ratio Value
Debt Service Coverage -52.14
Interest Coverage 0.0000
Short-Term Operating Cash Flow Coverage -43.22
Operating Cash Flow Coverage -9.76
Capital Expenditure Coverage -43.42
Dividend + Capital Expenditure Coverage -43.42

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 0.00
EPS -2.921
Debt/Share 0.2410
Cash/Share 4.95
Book Value/Share 5.78
Tangible BV/Share 5.78
Equity/Share 5.78
Operating Cash Flow/Share -2.352
Capital Expenditure/Share 0.054
FCF/Share -2.406

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 1.000
Earnings Before Tax/EBIT 0.923
Price/Fair Value 2.86
Debt/Market Cap 0.0033
Effective Tax Rate -0.0%
Enterprise Value Multiple -5.49